Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial (vol 29, pg 2825, 2023)

被引：1

作者：

Galsky, Matthew D.

Daneshmand, Siamak

Izadmehr, Sudeh

Gonzalez-Kozlova, Edgar

Chan, Kevin G.

Lewis, Sara

Achkar, Bassam El

Dorff, Tanya B.

Cetnar, Jeremy Paul

Neil, Brock O.

D'Souza, Anishka

Mamtani, Ronac

Kyriakopoulos, Christos

Jun, Tomi

Gogerly-Moragoda, Mahalya

Brody, Rachel

Xie, Hui

Nie, Kai

Kelly, Geoffrey

Horowitz, Amir

Kinoshita, Yayoi

Ellis, Ethan

Nose, Yohei

Ioannou, Giorgio

Cabal, Rafael

Del Valle, Diane M.

Haines, G. Kenneth

Wang, Li

Mouw, Kent W.

Samstein, Robert M.

Mehrazin, Reza

Bhardwaj, Nina

Yu, Menggang

Zhao, Qianqian

Kim-Schulze, Seunghee

Sebra, Robert

Zhu, Jun

Gnjatic, Sacha

Sfakianos, John

Pal, Sumanta K.

机构：

[1] Icahn School of Medicine at Mount Sinai,Division of Hematology and Medical Oncology

[2] Tisch Cancer Institute,Department of Urology

[3] Icahn School of Medicine at Mount Sinai,Department of Oncological Sciences

[4] Keck School of Medicine of USC,Department of Urology

[5] Norris Comprehensive Cancer Center,Department of Radiology

[6] Tisch Cancer Institute,Department of Medical Oncology & Therapeutics

[7] Icahn School of Medicine at Mount Sinai,Division of Hematology and Medical Oncology

[8] City of Hope Comprehensive Cancer Center,Department of Urology

[9] Tisch Cancer Institute,Division of Hematology and Medical Oncology

[10] Icahn School of Medicine at Mount Sinai,Division of Hematology and Medical Oncology

[11] City of Hope Comprehensive Cancer Center,Division of Hematology and Medical Oncology

[12] Oregon Health and Science University,Department of Pathology

[13] University of Utah,Department of Genetics and Genomic Sciences

[14] Keck School of Medicine of USC,Department of Pathology, Molecular and Cell

[15] Norris Comprehensive Cancer Center,based Medicine

[16] University of Pennsylvania Abramson Cancer Center,Department of Radiation Oncology

[17] University of Wisconsin Carbone Cancer Center,Department of Radiation Oncology

[18] Genentech,Department of Urology

[19] Tisch Cancer Institute,Department of Biostatistics and Medical Informatics

[20] Icahn School of Medicine at Mount Sinai,undefined

[21] Human Immune Monitoring Center,undefined

[22] Icahn School of Medicine at Mount Sinai,undefined

[23] Precision Immunology Institute,undefined

[24] Icahn School of Medicine at Mount Sinai,undefined

[25] Icahn School of Medicine at Mount Sinai,undefined

[26] Icahn Institute for Data Science and Genomic Technology,undefined

[27] Icahn School of Medicine at Mount Sinai,undefined

[28] Icahn School of Medicine at Mount Sinai,undefined

[29] Gene Dx,undefined

[30] Dana-Farber Cancer Institute/Brigham & Women’s Hospital,undefined

[31] Harvard Medical School,undefined

[32] Tisch Cancer Institute,undefined

[33] Icahn School of Medicine at Mount Sinai,undefined

[34] Tisch Cancer Institute,undefined

[35] Icahn School of Medicine at Mount Sinai,undefined

[36] University of Wisconsin Carbone Cancer Center,undefined

[37] Formerly with the Icahn School of Medicine at Mount Sinai,undefined

来源：

NATURE MEDICINE | 2024年 / 30卷 / 4期

关键词：

D O I：

10.1038/s41591-024-02814-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1211 / 1211

页数：1

共 50 条

[1] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Matthew D. Galsky
Siamak Daneshmand
Sudeh Izadmehr
Edgar Gonzalez-Kozlova
Kevin G. Chan
Sara Lewis
Bassam El Achkar
Tanya B. Dorff
Jeremy Paul Cetnar
Brock O. Neil
Anishka D’Souza
Ronac Mamtani
Christos Kyriakopoulos
Tomi Jun
Mahalya Gogerly-Moragoda
Rachel Brody
Hui Xie
Kai Nie
Geoffrey Kelly
Amir Horowitz
Yayoi Kinoshita
Ethan Ellis
Yohei Nose
Giorgio Ioannou
Rafael Cabal
Diane M. Del Valle
G. Kenneth Haines
Li Wang
Kent W. Mouw
Robert M. Samstein
Reza Mehrazin
Nina Bhardwaj
Menggang Yu
Qianqian Zhao
Seunghee Kim-Schulze
Robert Sebra
Jun Zhu
Sacha Gnjatic
John Sfakianos
Sumanta K. Pal
Nature Medicine, 2023, 29 : 2825 - 2834
[2] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Galsky, Matthew D.
Daneshmand, Siamak
Izadmehr, Sudeh
Gonzalez-Kozlova, Edgar
Chan, Kevin G.
Lewis, Sara
Achkar, Bassam El
Dorff, Tanya B.
Cetnar, Jeremy Paul
Neil, Brock O.
D'Souza, Anishka
Mamtani, Ronac
Kyriakopoulos, Christos
Jun, Tomi
Gogerly-Moragoda, Mahalya
Brody, Rachel
Xie, Hui
Nie, Kai
Kelly, Geoffrey
Horwitz, Amir
Kinoshita, Yayoi
Ellis, Ethan
Nose, Yohei
Ioannou, Giorgio
Cabal, Rafael
Haines, G. Kenneth
Wang, Li
Mouw, Kent W.
Samstein, Robert M.
Mehrazin, Reza
Bhardwaj, Nina
Yu, Menggang
Zhao, Qianqian
Kim-Schulze, Seunghee
Sebra, Robert
Zhu, Jun
Gnjatic, Sacha
Sfakianos, John
Pal, Sumanta K.
NATURE MEDICINE, 2023, 29 (11) : 2825 - +
[3] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Moschini, Marco
Necchi, Andrea
Montorsi, Francesco
EUROPEAN UROLOGY, 2024, 85 (05) : 500 - 501
[4] Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Matthew D. Galsky
Siamak Daneshmand
Sudeh Izadmehr
Edgar Gonzalez-Kozlova
Kevin G. Chan
Sara Lewis
Bassam El Achkar
Tanya B. Dorff
Jeremy Paul Cetnar
Brock O. Neil
Anishka D’Souza
Ronac Mamtani
Christos Kyriakopoulos
Tomi Jun
Mahalya Gogerly-Moragoda
Rachel Brody
Hui Xie
Kai Nie
Geoffrey Kelly
Amir Horowitz
Yayoi Kinoshita
Ethan Ellis
Yohei Nose
Giorgio Ioannou
Rafael Cabal
Diane M. Del Valle
G. Kenneth Haines
Li Wang
Kent W. Mouw
Robert M. Samstein
Reza Mehrazin
Nina Bhardwaj
Menggang Yu
Qianqian Zhao
Seunghee Kim-Schulze
Robert Sebra
Jun Zhu
Sacha Gnjatic
John Sfakianos
Sumanta K. Pal
Nature Medicine, 2024, 30 : 1211 - 1211
[5] Organ-sparing treatment in muscle-invasive bladder cancer
Dunst, J
Diestelhorst, A
Kühn, R
Müller, AC
Scholz, HJ
Fornara, P
STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (10) : 632 - 637
[6] Organ-sparing precision treatment for muscle-invasive bladder cancer
Li, Roger
NATURE MEDICINE, 2023, 29 (11) : 2709 - 2710
[7] Organ-sparing precision treatment for muscle-invasive bladder cancer
Roger Li
Nature Medicine, 2023, 29 : 2709 - 2710
[8] Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
Witjes, J. Alfred
Feikema, Astrid A. H.
CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7833 - 7839
[9] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
Kaneko, Gou
Kikuchi, Eiji
Matsumoto, Kazuhiro
Obata, Jun
Nakamura, So
Miyajima, Akira
Oya, Mototsugu
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
[10] Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
Kim, Hongsik
Jeong, Byong Chang
Hong, Joohyun
Kwon, Ghee Young
Kim, Chan Kyo
Park, Won
Pyo, Hongryull
Song, Wan
Sung, Hyun Hwan
Hong, Jung Yong
Park, Se Hoon
CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 636 - 642

← 1 2 3 4 5 →